Ann: Positive results reaffirm plans to advance ATL1102 to P2b, page-51

When you really get down to it - it's a pretty long game still - no clarification as to when they expect to commence a IIb or gain the EMA approval ? - I'd assume Q1 2020 EMA then first dosing 2H 2020 ? 12 months dosing plays out to at least 24 months for completion from here ? and that's assuming that recruitment goes relatively fast …. but that will also come down to trial size which we wont have until later - i'll guess 30-80 participants. Sure the likelihood that successful IIb may lead to early access - but still a while to wait ?

I did think Goolsbee's opening might have got people a little more excited though and traders to pump it ?